# What Is Liraglutide?
Liraglutide is a GLP-1 receptor agonist studied for metabolic research.
## Key Facts
- Type: GLP-1 receptor agonist
- Research status: Preclinical / Laboratory research
- Molecular information: C172H266N43O51
- Available specifications: 5mg, 30mg, 10mg
- Testing: HPLC, Mass Spectrometry
## Detailed Overview
Liraglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist that has been studied extensively in metabolic research. It has been investigated for its effects on glucose-dependent insulin secretion, glucagon suppression, and appetite regulation through GLP-1 receptor activation. Published research has examined its pharmacokinetics and metabolic effects. RaySunPeptide supplies Liraglutide for qualified research and laboratory applications.
Liraglutide is a GLP-1 receptor agonist studied for metabolic research. It is supplied by RaySunPeptide as a research-grade compound for qualified laboratory and research applications.
Published research on Liraglutide remains at the preclinical and laboratory investigation stage. Researchers studying Liraglutide have access to peer-reviewed publications through PubMed that document various aspects of its chemical properties and biological activity.
RaySunPeptide manufactures and supplies Liraglutide with the following quality assurances:
- **Purity**: ≥98% verified by HPLC
- **Testing**: Each batch undergoes HPLC and Mass Spectrometry analysis
- **Documentation**: Certificates of Analysis (COA) available upon request
- **Packaging**: Available in multiple vial configurations
> **Note**: Liraglutide is supplied for qualified research and laboratory purposes only. It is not intended for human consumption, therapeutic use, or any application outside of controlled research environments.
## References
- PubMed database (pubmed.ncbi.nlm.nih.gov) for peer-reviewed research publications on Liraglutide
- RaySunPeptide product specifications and Certificates of Analysis
## Related Products
- [Semaglutide](/products/semaglutide)
- [Tirzepatide](/products/tirzepatide)
- [AOD9604](/products/aod9604)
- [Retatrutide](/products/retatrutide)
## About RaySunPeptide
RaySunPeptide is a peptide manufacturer and supplier based in Southeast Asia, providing research-grade peptides, proteins, and related compounds for qualified research, laboratory, and B2B applications. All products undergo rigorous quality control testing and are supplied with Certificates of Analysis (COA).
What Is Liraglutide?
Quick Answer
Liraglutide is a GLP-1 receptor agonist studied for metabolic research.
Key Facts
- Type: GLP-1 receptor agonist
- Research status: Preclinical / Laboratory research
- Molecular information: C172H266N43O51
- Available specifications: 5mg, 30mg, 10mg
- Testing: HPLC, Mass Spectrometry